Galmed PharmaceuticalsEOCN
13F holders, Q1 2025 (March 31)13holders +1
2new positions
1sold out
$1.44avg. 13F price*
At the end of Q1 2025, 13 institutions reported holding Galmed Pharmaceuticals Ltd. (EOCN) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 1 sold out. The largest holders were Schonfeld Strategic Advisors LLC ($36K), Virtu Financial LLC ($16K) and Two Sigma Securities, LLC ($16K).
- Company
- Galmed Pharmaceuticals Ltd.
- CUSIP
- M47238148
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $32K |
| Exits | 1 | $188 |
All 13F filers, Q4 2024 → Q1 2025: 22,145 shares bought and 11,036 shares sold, net +11,109 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -0.8% | 25,194 | $36K |
| Virtu Financial LLC | 0.00% | New | 11,126 | $16K |
| Two Sigma Securities, LLC | 0.00% | New | 11,019 | $16K |
| Morgan Stanley | 0.00% | Reduce -41.1% | 7,385 | $11K |
| UBS Group AG | 0.00% | Reduce -83.6% | 1,104 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 16 | $23 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 14 | $20 |
| Wells Fargo & Company | 0.00% | Reduce -50.0% | 9 | $13 |
| Osaic Holdings, Inc. | 0.00% | No change | 5 | $7 |
| Allworth Financial LP | 0.00% | No change | 2 | $4 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 1 | $2 |
| Dogwood Wealth Management LLC | 0.00% | No change | 1 | $1 |
| Tsfg, LLC | 0.00% | No change | 17 | $0 |
"% of holder's portfolio" is EOCN's weight in each manager's 13F, not the share of Galmed Pharmaceuticals Ltd. the manager owns.